These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23280026)

  • 1. Latest advancements in the pharmacological treatment of binge eating disorder.
    Marazziti D; Corsi M; Baroni S; Consoli G; Catena-Dell'Osso M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2102-7. PubMed ID: 23280026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatment options of binge eating disorder.
    Marazziti D; Rossi L; Baroni S; Consoli G; Hollander E; Catena-Dell'Osso M
    Curr Med Chem; 2011; 18(33):5159-64. PubMed ID: 22050761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate for binge-eating disorder associated with obesity.
    Tata AL; Kockler DR
    Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of binge eating disorder: update review and synthesis.
    Reas DL; Grilo CM
    Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Supervised off-label prescribing of topiramate for binge eating disorder within the system CAMTEA].
    Guardia D; Rolland B; Deheul S; Danel T; Bordet R; Cottencin O
    Therapie; 2012; 67(5):480-1. PubMed ID: 23241259
    [No Abstract]   [Full Text] [Related]  

  • 7. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
    Aigner M; Treasure J; Kaye W; Kasper S;
    World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of binge-eating disorder: a review.
    Goracci A; di Volo S; Casamassima F; Bolognesi S; Benbow J; Fagiolini A
    J Addict Med; 2015; 9(1):1-19. PubMed ID: 25629881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
    McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
    Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT).
    Munsch S; Biedert E; Meyer AH; Herpertz S; Beglinger C
    Physiol Behav; 2009 Apr; 97(1):14-20. PubMed ID: 19419677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to the management of binge eating disorder.
    Brownley KA; Peat CM; La Via M; Bulik CM
    Drugs; 2015 Jan; 75(1):9-32. PubMed ID: 25428709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate for abnormal eating behaviour in frontotemporal dementia.
    Singam C; Walterfang M; Mocellin R; Evans A; Velakoulis D
    Behav Neurol; 2013 Jan; 27(3):285-6. PubMed ID: 23548883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current drug treatment of patients with bulimia nervosa and binge-eating disorder: selective serotonin reuptake inhibitors versus mood stabilizers.
    Bellini M; Merli M
    Int J Psychiatry Clin Pract; 2004; 8(4):235-43. PubMed ID: 24930552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery.
    Guerdjikova AI; Kotwal R; McElroy SL
    Obes Surg; 2005 Feb; 15(2):273-7. PubMed ID: 15802073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin levels after a cold pressor stress test in obese women with binge eating disorder.
    Gluck ME; Yahav E; Hashim SA; Geliebter A
    Psychosom Med; 2014 Jan; 76(1):74-9. PubMed ID: 24367126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.
    Guerdjikova AI; McElroy SL; Winstanley EL; Nelson EB; Mori N; McCoy J; Keck PE; Hudson JI
    Int J Eat Disord; 2012 Mar; 45(2):281-9. PubMed ID: 21744377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate therapeutic approach to binge-eating disorder: combined nutritional, psychological and pharmacological treatment.
    Brambilla F; Samek L; Company M; Lovo F; Cioni L; Mellado C
    Int Clin Psychopharmacol; 2009 Nov; 24(6):312-7. PubMed ID: 19794312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.
    McElroy SL; Guerdjikova AI; Winstanley EL; O'Melia AM; Mori N; McCoy J; Keck PE; Hudson JI
    Int J Eat Disord; 2011 Jan; 44(1):81-90. PubMed ID: 21080416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Leu72Met polymorphism of the ghrelin gene is significantly associated with binge eating disorder.
    Monteleone P; Tortorella A; Castaldo E; Di Filippo C; Maj M
    Psychiatr Genet; 2007 Feb; 17(1):13-6. PubMed ID: 17167339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight.
    Zilberstein B; Pajecki D; Garcia de Brito AC; Gallafrio ST; Eshkenazy R; Andrade CG
    Obes Surg; 2004; 14(6):802-5. PubMed ID: 15318986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.